GO:0062156 mitochondrial ATP-gated potassium channel activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0062156 defines the molecular function that enables ATP-dependent diffusion of potassium ions across the mitochondrial inner membrane.
• This activity is distinct from sarcolemmal ATP-gated potassium channels and is selectively targeted by compounds such as SNC-80 and BMS-191095 [1,3].
• Pharmacological opening of mitochondrial ATP-gated potassium channels can trigger preconditioning but may also carry proarrhythmic risk [1,3].
• Blockers of ATP-gated potassium channels modulate neuronal activity under hypoxia, linking the channel to cellular stress responses.
• The channel is implicated in inflammatory signaling, as P2X7 receptor antagonism reduces IL-1β release in autoimmune exocrinopathy models.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential to dissect the channel's role in disease.
Description
The mitochondrial ATP-gated potassium channel (mitoK-ATP) is a molecular function defined by the Gene Ontology term GO:0062156, which enables the ATP-dependent diffusion of potassium ions across the mitochondrial inner membrane. This activity is critical for regulating mitochondrial membrane potential, volume, and reactive oxygen species production, and it has been implicated in cytoprotection and preconditioning [1,3]. Unlike sarcolemmal ATP-gated potassium channels, the mitochondrial channel is pharmacologically distinct and can be selectively modulated by compounds such as SNC-80 and BMS-191095 [1,3]. Researchers study this channel to understand how mitochondrial ion flux contributes to cellular stress responses, including hypoxia and inflammation [2,4]. The channel's role in disease is an active area of investigation, with evidence linking it to cardiac arrhythmia risk and inflammatory conditions [1,4]. Understanding the molecular mechanism of GO:0062156 is therefore essential for developing targeted therapies that modulate mitochondrial potassium homeostasis.
mitochondrial ATP-gated potassium channel activity At A Glance
| GO ID | GO:0062156 |
|---|---|
| GO term | mitochondrial ATP-gated potassium channel activity |
| Ontology | molecular_function |
| Synonym | mitochondrial potassium channel activity, mitoK-ATP activity |
| Major function | Enables ATP-dependent diffusion of potassium ions across the mitochondrial inner membrane |
| Localization | Mitochondrial inner membrane |
| Regulation | ATP-dependent gating; modulated by pharmacological openers and blockers |
| Disease relevance | Cardiac arrhythmia, inflammation, hypoxia response |
What Is GO:0062156?
GO:0062156, mitochondrial ATP-gated potassium channel activity, is a molecular function that enables the ATP-dependent diffusion of potassium ions across the mitochondrial inner membrane. This activity is synonymous with mitochondrial potassium channel activity and mitoK-ATP activity. It is distinct from other potassium channel activities because it is localized to mitochondria and regulated by intracellular ATP levels, allowing the channel to couple cellular energy status to mitochondrial ion flux.
Why Is mitochondrial ATP-gated potassium channel activity Important in Cell Biology?
GO:0062156 is important because it links cellular energy status to mitochondrial ion homeostasis, influencing processes such as mitochondrial membrane potential, volume regulation, and reactive oxygen species production [1,3]. Pharmacological modulation of this channel can induce preconditioning, protecting tissues from ischemic damage, but selective opening may also increase the risk of ventricular proarrhythmia. In neurons, ATP-gated potassium channel blockers alter activity variations triggered by short-term hypoxia, suggesting a role in neuronal stress responses. Furthermore, mitochondrial dysfunction and inflammatory signaling are connected through pathways involving ATP-gated potassium channels, as shown by reduced IL-1β release upon P2X7 receptor antagonism in autoimmune exocrinopathy models. Thus, understanding this molecular function is critical for developing therapies for cardiac, neurological, and inflammatory diseases.
• Regulates mitochondrial membrane potential and volume, impacting cellular energy metabolism.
• Mediates cytoprotection through ischemic preconditioning mechanisms.
• Selective opening may carry proarrhythmic risk, highlighting the need for targeted modulation.
• Modulates neuronal activity under hypoxic conditions, linking to stroke and neurodegeneration.
• Connects to inflammatory pathways, as P2X7 receptor antagonism reduces IL-1β release.
• Potential therapeutic target for cardiac arrhythmias and ischemic injury [1,3].
• Involved in autoimmune exocrinopathy and inflammation.
• Provides a model for studying mitochondrial ion channels in health and disease [1,2].
• Enables research on ATP-dependent gating mechanisms in mitochondria.
• Offers a target for pharmacological preconditioning strategies.
What Happens During mitochondrial ATP-gated potassium channel activity?
ATP-dependent gating
In simple terms: The channel opens or closes depending on ATP levels.
The mitochondrial ATP-gated potassium channel is regulated by intracellular ATP, which binds to the channel and modulates its open probability. Under conditions of low ATP, such as during ischemia, the channel opens to allow potassium influx into the mitochondrial matrix. This ATP-dependent gating is a hallmark of mitoK-ATP activity and distinguishes it from other potassium channels.
Potassium diffusion across the inner membrane
In simple terms: Potassium ions move into the mitochondria.
Once opened, the channel enables the diffusion of potassium ions across the mitochondrial inner membrane down their electrochemical gradient. This potassium influx affects mitochondrial membrane potential and matrix volume, which are critical for maintaining mitochondrial function.
Pharmacological activation and preconditioning
In simple terms: Drugs can open the channel to protect tissues.
Selective openers of the mitochondrial ATP-gated potassium channel, such as SNC-80, can induce preconditioning, a protective mechanism against ischemic injury. However, selective opening of the mitochondrial channel versus the sarcolemmal channel may have different effects on arrhythmia risk, with mitochondrial opening potentially increasing proarrhythmic risk in some contexts.
Role in hypoxic neuronal responses
In simple terms: The channel helps neurons respond to low oxygen.
In hippocampal slices, blockers of ATP-gated potassium channels alter the activity variations of CA1 pyramidal neurons triggered by short-term hypoxia. This suggests that mitochondrial ATP-gated potassium channel activity is involved in neuronal stress responses and may modulate excitability under hypoxic conditions.
Inflammatory signaling connection
In simple terms: The channel may influence inflammation.
P2X7 receptor antagonism, which can affect ATP-gated potassium channel activity, prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy. This links mitochondrial ATP-gated potassium channel function to inflammatory pathways, although the exact mechanism requires further study.
Key Genes Involved in GO:0062156 mitochondrial ATP-gated potassium channel activity
The following genes and proteins are associated with mitochondrial ATP-gated potassium channel activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KCNJ1 | Potassium channel subunit | Potential component of mitoK-ATP; studied in ion transport |
| KCNJ8 | Potassium channel subunit | Forms ATP-sensitive potassium channels; may contribute to mitoK-ATP |
| KCNJ11 | Potassium channel subunit | ATP-sensitive potassium channel; implicated in mitochondrial function |
| ABCC8 | Sulfonylurea receptor | Regulatory subunit of ATP-sensitive potassium channels |
| ABCC9 | Sulfonylurea receptor | Regulatory subunit; may modulate mitoK-ATP activity |
| P2RX7 | ATP-gated ion channel | Involved in IL-1β release and inflammation; linked to mitoK-ATP |
| SNC-80 | Pharmacological opener | Selectively activates mitochondrial ATP-gated potassium channel |
| BMS-191095 | Pharmacological opener | Selective mitochondrial channel opener; used in preconditioning studies |
| Glibenclamide | Pharmacological blocker | Blocks ATP-gated potassium channels; used to study mitoK-ATP |
| 5-HD | Pharmacological blocker | Mitochondrial ATP-gated potassium channel blocker; used in preconditioning research |
| Diazoxide | Pharmacological opener | Opens mitochondrial ATP-gated potassium channels; induces preconditioning |
| ATP | Endogenous ligand | Regulates channel gating; ATP levels determine open probability |
| Potassium ion | Substrate | Diffuses through the channel across the inner membrane |
| Mitochondrial inner membrane | Location | Site of channel activity and potassium diffusion |
| Reactive oxygen species | Downstream effector | Modulated by mitoK-ATP activity; involved in signaling |
| IL-1β | Inflammatory cytokine | Release reduced by P2X7 antagonism; linked to mitoK-ATP |
| CA1 pyramidal neurons | Cell type | Activity modulated by ATP-gated potassium channel blockers under hypoxia |
How Is mitochondrial ATP-gated potassium channel activity Regulated?
The activity of the mitochondrial ATP-gated potassium channel is primarily regulated by intracellular ATP levels, which bind to the channel and control its open probability. Pharmacological agents such as SNC-80 and BMS-191095 can selectively open the channel, while blockers like glibenclamide and 5-HD inhibit its activity [1,2,3]. Additionally, P2X7 receptor signaling may influence channel function, as P2X7 antagonism reduces IL-1β release in inflammatory models. The channel's activity is also modulated by hypoxia, which alters neuronal activity in hippocampal slices.
mitochondrial ATP-gated potassium channel activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KCNJ11 | Cardiac arrhythmia | Knockout mouse; patch-clamp of cardiomyocytes |
| ABCC8 | Ischemic preconditioning | Point mutation knock-in; ischemia-reperfusion model |
| P2RX7 | Autoimmune exocrinopathy | Knockout mouse; IL-1β release assay |
| KCNJ8 | Hypoxic neuronal injury | Overexpression in hippocampal neurons; hypoxia challenge |
| ABCC9 | Ventricular proarrhythmia | Knock-in mouse; ECG telemetry |
Cardiac arrhythmia and preconditioning
Selective opening of the mitochondrial ATP-gated potassium channel has been associated with an increased risk of ventricular proarrhythmia, whereas opening of the sarcolemmal channel may be protective. This highlights the need for selective modulators to avoid adverse cardiac effects. Conversely, activation of the mitochondrial channel by SNC-80 induces preconditioning, which protects against ischemic injury. Thus, the channel plays a dual role in cardiac disease, with both therapeutic potential and risk.
Hypoxic neuronal injury
In hippocampal slices, blockers of ATP-gated potassium channels affect the activity variations of CA1 pyramidal neurons triggered by short-term hypoxia. This suggests that mitochondrial ATP-gated potassium channel activity contributes to neuronal responses to hypoxia, which is relevant to stroke and neurodegenerative conditions.
Autoimmune exocrinopathy and inflammation
P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy. Since P2X7 is an ATP-gated channel, this implicates ATP-gated potassium channel activity in inflammatory pathways, though the specific role of the mitochondrial channel requires further investigation.
From mitochondrial ATP-gated potassium channel activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of mitoK-ATP function affect cardiac preconditioning? | Knockout of KCNJ11 or ABCC8 in mice [1,3] |
| How do point mutations in the channel alter ATP sensitivity? | Point mutation knock-in of KCNJ11 in cell lines |
| Can overexpression of the channel protect against hypoxia? | Overexpression of KCNJ8 in neuronal cultures |
| What is the role of the channel in inflammation? | Knockout of P2RX7 in mouse models of exocrinopathy |
| Does selective channel opening increase arrhythmia risk? | Knock-in of human variant into mouse ABCC9 |
| How does the channel interact with P2X7 signaling? | Double knockout of P2RX7 and KCNJ11 |
How to Study the mitochondrial ATP-gated potassium channel activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp | Channel open probability and conductance | Functional characterization of mitoK-ATP |
| Pharmacological profiling | Selective activation or inhibition | Distinguishing mitochondrial vs sarcolemmal channels [1,3] |
| Hypoxia-reoxygenation assay | Cell survival and mitochondrial function | Preconditioning studies [2,3] |
| IL-1β ELISA | Inflammatory cytokine release | Autoimmune exocrinopathy models |
| Mitochondrial membrane potential assay | Changes in ΔΨm | Channel activity effects on mitochondria |
| Reactive oxygen species detection | ROS production | Downstream signaling of mitoK-ATP |
| Electron microscopy | Mitochondrial morphology | Volume regulation by potassium flux |
| CRISPR knockout | Gene function loss | Target validation for channel components [1,4] |
Patch-clamp electrophysiology
Patch-clamp recordings of mitochondrial inner membrane vesicles or mitoplasts can directly measure ATP-gated potassium channel activity. This method allows researchers to assess open probability, conductance, and ATP sensitivity in real time, providing functional validation of channel modulators.
Pharmacological profiling
Using selective openers (e.g., SNC-80, BMS-191095) and blockers (e.g., glibenclamide, 5-HD) in cell-based assays can dissect the contribution of mitochondrial versus sarcolemmal channels [1,3]. Such profiling is essential for understanding the specific role of GO:0062156 in cellular responses.
Hypoxia and preconditioning models
In vitro hypoxia-reoxygenation models and in vivo ischemia-reperfusion models can be used to study the channel's role in cytoprotection [2,3]. Neuronal slice cultures subjected to short-term hypoxia are particularly useful for assessing effects on CA1 pyramidal neuron activity.
Inflammatory cytokine assays
Measuring IL-1β release from salivary epithelial cells or other immune cells upon P2X7 receptor antagonism can link ATP-gated potassium channel activity to inflammation. This method helps evaluate the channel's contribution to autoimmune exocrinopathy.
How CRISPR Can Be Used to Study GO:0062156 mitochondrial ATP-gated potassium channel activity
Knockout
CRISPR knockout of genes encoding putative channel subunits (e.g., KCNJ11, ABCC8) can abolish mitochondrial ATP-gated potassium channel activity, allowing researchers to test its role in preconditioning and arrhythmia [1,3]. Knockout models are essential for establishing causality between the channel and disease phenotypes.
Point Mutation
Introducing point mutations that alter ATP sensitivity or ion selectivity can mimic human variants and help dissect the channel's gating mechanism. Such models are valuable for understanding how specific residues contribute to ATP-dependent potassium diffusion.
Knock-in
Knock-in of reporter tags or human disease-associated variants into the endogenous locus enables precise tracking of channel expression and function in vivo. This approach is particularly useful for studying tissue-specific effects of the channel in cardiac and neuronal tissues [1,2].
Overexpression
Overexpression of channel subunits in cell lines or primary neurons can enhance mitochondrial ATP-gated potassium channel activity, facilitating studies on cytoprotection and hypoxia responses. Overexpression models help identify downstream signaling pathways activated by the channel.
How EDITGENE Supports mitochondrial ATP-gated potassium channel activity Research
Researchers studying mitochondrial ATP-gated potassium channel activity-related genes often need to determine whether a candidate gene is causally involved in mitochondrial ion homeostasis, preconditioning, or inflammation. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell and animal models, enabling rigorous functional validation of GO:0062156 components.
Contact EDITGENE today to design your custom CRISPR model for mitochondrial ATP-gated potassium channel activity research.
Frequently Asked Questions About mitochondrial ATP-gated potassium channel activity
What is mitochondrial ATP-gated potassium channel activity?
It is a molecular function defined by GO:0062156 that enables ATP-dependent diffusion of potassium ions across the mitochondrial inner membrane.
What genes are involved in mitochondrial ATP-gated potassium channel activity?
Genes such as KCNJ11, ABCC8, KCNJ8, and P2RX7 are implicated in this activity, based on their roles in ATP-sensitive potassium channels and inflammation [1,4].
How is mitochondrial ATP-gated potassium channel activity regulated?
It is regulated by intracellular ATP levels and can be modulated by pharmacological openers like SNC-80 and blockers like glibenclamide [1,2,3].
What diseases are associated with mitochondrial ATP-gated potassium channel activity?
Cardiac arrhythmia, ischemic preconditioning, hypoxic neuronal injury, and autoimmune exocrinopathy have been linked to this channel [1,2,3,4].
What is the difference between mitochondrial and sarcolemmal ATP-gated potassium channels?
Mitochondrial channels are located on the inner mitochondrial membrane and have distinct pharmacological profiles; selective opening of the mitochondrial channel may increase proarrhythmic risk compared to sarcolemmal opening.
How can I study mitochondrial ATP-gated potassium channel activity in the lab?
Patch-clamp electrophysiology, pharmacological profiling, hypoxia models, and CRISPR knockout are common methods [1,2,3,4].
What are the pharmacological tools for mitoK-ATP?
SNC-80 and BMS-191095 are openers, while glibenclamide and 5-HD are blockers used to study the channel [1,2,3].
Does mitochondrial ATP-gated potassium channel activity play a role in inflammation?
Yes, P2X7 receptor antagonism, which affects ATP-gated channels, reduces IL-1β release in autoimmune exocrinopathy models.
Can CRISPR be used to study mitochondrial ATP-gated potassium channel activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the channel's function [1,4].
What is the GO ID for mitochondrial ATP-gated potassium channel activity?
The GO ID is GO:0062156.
Conclusion
GO:0062156, mitochondrial ATP-gated potassium channel activity, is a critical molecular function that couples cellular energy status to mitochondrial ion homeostasis. Its pharmacological modulation has therapeutic potential for ischemic preconditioning but also carries risks such as proarrhythmia [1,3]. The channel is implicated in neuronal hypoxia responses and inflammatory pathways, underscoring its broad physiological relevance [2,4]. Advanced CRISPR models and bioinformatics tools from EDITGENE can accelerate research into this channel and its role in disease.
References
- 1. Fischbach PS et al.. 2004. Risk of ventricular proarrhythmia with selective opening of the myocardial sarcolemmal versus mitochondrial ATP-gated potassium channel.. J Pharmacol Exp Ther 309(2):554-9 PMID: 14747611
- 2. Levin SG et al.. 2013. Comparison of effects of ATP-gated potassium channel blockers on activity variations of rat CA1 pyramidal neurons in hippocampal slices triggered by short-term hypoxia.. Bull Exp Biol Med 154(4):441-4 PMID: 23486576
- 3. Fischbach PS et al.. 2003. SNC-80-induced preconditioning: selective activation of the mitochondrial adenosine triphosphate-gated potassium channel.. J Cardiovasc Pharmacol 41(5):744-50 PMID: 12717105
- 4. Khalafalla MG et al.. 2017. P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy.. J Biol Chem 292(40):16626-16637 PMID: 28798231
